Analysts Viewpoint Quince Therapeutics Inc’s latest rating changes from various analysts In a filing, Quince Therapeutics Inc revealed its CEO AND CHIEF MEDICAL OFFICER Thye Dirk acquired Company’s shares for reported
Stock Earnings Quince Therapeutics Inc [QNCX] stock for 53,900 USD was acquired by Thye Dirk Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Quince Therapeutics
Stock Earnings Potential Price Increase for Quince Therapeutics Inc (QNCX) After Recent Insider Activity Quince Therapeutics Inc’s recently made public that its CEO AND CHIEF MEDICAL OFFICER Thye Dirk acquired Company’s shares for reported